Eli Lilly
LLY
$588.15
Share price
0.42%
Change (1 day)
59.27%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Market capitalization of Eli Lilly (LLY)
Market cap: $558.33 Billion
As of December 2023 Eli Lilly has a market cap of $558.33 Billion. This makes Eli Lilly the world's 10th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eli Lilly from 2001 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $558.33 B | 60.62% |
| 2022 | $347.61 B | 31.56% |
| 2021 | $264.22 B | 63.6% |
| 2020 | $161.50 B | 28.34% |
| 2019 | $125.84 B | 2.83% |
| 2018 | $122.38 B | 31.6% |
| 2017 | $92.99 B | 14.54% |
| 2016 | $81.19 B | -12.81% |
| 2015 | $93.12 B | 21.54% |
| 2014 | $76.62 B | 34.53% |
| 2013 | $56.95 B | 0.73% |
| 2012 | $56.54 B | 17.52% |
| 2011 | $48.11 B | 19.17% |
| 2010 | $40.37 B | -1.6% |
| 2009 | $41.03 B | -10.38% |
| 2008 | $45.78 B | -24.4% |
| 2007 | $60.56 B | 2.72% |
| 2006 | $58.95 B | -7.81% |
| 2005 | $63.95 B | -0.44% |
| 2004 | $64.23 B | -18.72% |
| 2003 | $79.03 B | 10.88% |
| 2002 | $71.27 B | -19.21% |
| 2001 | $88.22 B |
End of Day market cap according to different sources
On Dec 5th, 2023 the market cap of Eli Lilly was reported to be:
$558.33 Billion
$558.33 Billion
$558.33 Billion
$1.117 Trillion
$554.43 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $382.46 B | -31.50% | 🇺🇸 USA |
 Novartis NVS | $202.70 B | -63.70% | 🇨🇭 Switzerland |
 Pfizer PFE | $165.32 B | -70.39% | 🇺🇸 USA |
 AbbVie ABBV | $255.24 B | -54.28% | 🇺🇸 USA |
 Amgen AMGN | $145.80 B | -73.88% | 🇺🇸 USA |
 Sanofi SNY | $118.00 B | -78.87% | 🇫🇷 France |
 Merck MRK | $269.18 B | -51.79% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $102.20 B | -81.69% | 🇺🇸 USA |
 AstraZeneca AZN | $200.65 B | -64.06% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $75.01 B | -86.56% | 🇬🇧 UK |